TNTatit Nurseta

Tatit Nurseta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tatit Nurseta has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Induction of an 11 KDA Protein Epitope For Reducing Mrsa Bacterial Colony Counts Via Cellular and Humoral Adaptive Immune Responses In Postpartum MUS Musculus Infected With MRSA: A Strategy for Enhancing Public Health and Combating Antibiotic Resistance

    by Uswatun Hasanah, Sri Poeranto, Tatit Nurseta, I Wayan A. Wiyasa, Umi Kalsum, Muhammad Anas, Sumarno R. Prawiro, Edy Mustofa

    Objective: This study investigates how the 11 kDa protein epitope, from the cross-reaction between MRSA bacteria and L. reuteri, reduces MRSA colonies through adaptive immune responses (Th17, Th2), cytokines (IL-4, IL-22), and innate immunity (IgG antibodies) in postpartum Mus musculus. Method: A true experimental design was applied using Balb/c mice divided into seven groups, including controls and those treated with different combinations of L. reuteri, MRSA proteins, and peptides. Cellular immunity (Th17, Th2), cytokines (IL-4, IL-22), IgG antibodies, and MRSA colonies were measured post-treatment. Results & Discussion: The candidate vaccine enhanced cellular adaptive immunity (Th2, Th17), cytokine responses (IL-4, IL-22), and reduced MRSA colonies. IgG levels were notably higher in Groups K3 and K6 compared to K1. Conclusion: The 11 kDa protein epitope, from the MRSA-L. reuteri cross-reaction, effectively modulates adaptive immunity, reducing MRSA colonies in postpartum Mus musculus.

  • Open Access

    Risk of Malignancy Index 4 (RMI4) and Risk of Malignancy Index 3 (RMI3) as Diagnostic Tests for Adnexal Tumor

    by Tatit Nurseta, Yahya Irwanto, Nugrahanti Prasetyorini, Bambang Rahardjo, I Wayan Subage

    Objective: Comparing scoring with RMI3 and RMI4 in establishing the diagnosis of adnexal tumour in RSUD Dr. Saiful Anwar Malang.Methods: Prospective cohort study with samples of all patients suspected of having an adnexal tumour diagnosed in gynecology policlinic using gynecological oncology policlinic medical records at RSUD Dr. Saiful Anwar in the form of age, demographics, menopause status, Ca125, ultrasound results.Results: Between the RMI3 results and the results of histopathology, a contingency coeffi cient of 0.596 was obtained with a p-value of 0.000015 (p <0.05), with a PPV of 83%, an NPV of 91%. Between the RMI4 results and the histopathology results, a contingency coeffi cient of 0.657 with a p-value of 0.0000004 (p <0.05) was obtained, with a PPV of 92%, NPV of 95%. On the ROC curve, the area of the predicted results using the RMI4 score is higher than the RMI3 score.Conclusions: Using the RMI4 score results in more accurate predictions than the RMI3 score in detecting adnexal tumour malignancies.Keywords: adnexal tumours, diagnostic tests, ovarian tumours, risk of malignancy index, ultrasound. Abstrak Tujuan: Membandingkan Skoring RMI3 dan RMI4 dalam menegakkan diagnosis tumor adneksa di RSUD dr. Saiful Anwar Malang.Metode: penelitian kohort prospective dengan sampel semua pasien yang dicurigai menderita tumor adneksa yang didiagnosis di poli Ginekologi menggunakan data rekam medis poli Ginekologi Onkologi RSUD dr. Saiful Anwar berupa usia, demografi , status menopause, Ca125, hasil USG.Hasil: Antara hasil RMI3 dengan hasil hispatologi, didapatkan koefi sien kontingensi sebesar 0,596 dengan p-value 0,000015 (p<0,05), dengan PPV 83%, NPV 91%. Antara hasil RMI4 dengan hasil histopatologi, didapatkan koefisien kontingensi sebesar 0,657 dengan p-value 0,0000004 (p<0,05), dengan PPV 92%, NPV 95%. Pada kurva ROC, luas area hasil prediksi dengan menggunakan skor RMI4 lebih tinggi daripada skor RMI3.Kesimpulan: Menggunakan skor RMI4 menghasilkan prediksi yang lebih tepat daripada skor RMI3 dalam mendeteksi keganasan tumor adneksa.Kata kunci: risk of malignancy index, tumor adneksa, tumor ovarium, uji diagnostik, USG.